ERcast: Clinical Perspectives Podcast Preview

Subscription Required

SCAPE

Drew Kalnow, DO and Brit Long, MD

Sign in or Subscribe to listen.
5 starson Spotify
Sign in or Subscribe to view.Sign in or Subscribe to view.

The summary below is from an episode of ERcast: Clinical Perspectives

Sympathetic crashing acute pulmonary edema is an afterload-driven hypertensive emergency, not simply a fluid-overload problem. SCAPE presents with abrupt flash pulmonary edema, severe hypertension, and respiratory distress, and the early move is simultaneous noninvasive ventilation plus aggressive vasodilation rather than reflex diuresis.

SCAPE recognition and bedside diagnosis

  • Afterload surge physiology: SCAPE is a sympathetic surge syndrome in which abrupt vasoconstriction redistributes fluid into the lungs, so many patients are wet in the chest without being globally volume overloaded.
  • Rapid hypertensive presentation: The classic picture is sudden dyspnea over hours, marked hypertension, tachypnea, and hypoxia, helping separate SCAPE from slower decompensated heart failure that builds over days.
  • Clinical diagnosis first: SCAPE is primarily a bedside diagnosis, while ECG, troponin, BMP, CBC, and liver tests help uncover ischemia, renal injury, or another precipitating trigger.
  • POCUS lung findings: Bedside ultrasound outperforms chest radiography for early pulmonary edema; a practical rule is at least 3 B-lines in 2 bilateral lung zones. We get into the scan nuances in the episode.
  • Cardiac ultrasound clues: EPSS greater than 7 mm suggests reduced ejection fraction, and IVC assessment can add volume-status context when the exam does not clearly fit pure redistribution.

SCAPE treatment priorities

  • Immediate dual therapy: The first move is simultaneous NIPPV and high-dose nitroglycerin, because SCAPE improves when you rapidly unload the ventricle and reduce work of breathing.
  • Noninvasive ventilation benefit: CPAP or BPAP lowers preload and afterload while improving oxygenation, and lack of meaningful improvement within 15 to 20 minutes should raise concern for intubation.
  • Nitroglycerin first-line vasodilator: High-dose nitroglycerin is the core medication in hypertensive SCAPE, with repeated boluses and an infusion strategy built around the blood pressure response. We walk through the bedside dosing logic in the chapter.
  • Diuretics not reflex therapy: Routine early diuresis can miss the physiology, because many SCAPE patients have fluid redistribution rather than true excess volume; reserve loop diuretics for clear systemic congestion.
  • Medications to avoid: Beta blockers can worsen acute pump failure, and opioids are linked to higher mortality, intubation, and vasopressor use, making both poor default choices in early SCAPE.
  • Rescue vasodilator options: If maximal NIPPV and nitroglycerin are not enough, nicardipine or clevidipine are reasonable alternatives, with ACE inhibition as another option in selected patients.

Subscribe to ERcast: Clinical Perspectives to listen to the episode.

References:

  1. Long B, Brady WJ, Gottlieb M. Emergency medicine updates: Sympathetic crashing acute pulmonary edema. Am J Emerg Med. 2025 Apr;90:35-40. PMID: 39799613.
  2. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 May 3;145(18) PMID: 35363499.

Faculty